NASDAQ

Climb Bio, Inc. (CLYM)

♥ 713 Thanks from members

Live price chart, market sentiment, and community perspectives for Climb Bio, Inc. (NASDAQ: CLYM).

Member Opinions and Insights

Special Briefing

How to Live for 300 Years: The Longevity Sandbox

Explore plasma cleansing, somatic organ swaps, and BCI.

Explore →
Entity and Market Metadata
Sector: HealthcareIndustry: BiotechnologyFounder: Climb Bio Research TeamLeadership: Sujal Shah (CEO)Leadership: Jason S. Bowles (CFO)Holder: Bain Capital Life SciencesHolder: RA Capital ManagementHolder: Fidelity ManagementAutoimmune TherapeuticsMonoclonal AntibodiesImmunology Pipeline Drugs#CLYM#Climb Bio#Autoimmune biotech#NASDAQ health#Immunology drugs